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ABSTRACT 
 
The analysis of Next-Generation Sequencing (NGS) data for the identification of 
DNA genetic variants presents several bioinformatics challenges. The main 
requirements of the analysis are the accuracy and the reproducibility of results, as 
their clinical interpretation may be influenced by many variables, from the sample 
processing to the adopted bioinformatics algorithms. Targeted resequencing, which 
aim is the enrichment of genomic regions to identify genetic variants possibly 
associated to clinical diseases, bases the quality of its data on the depth and 
uniformity of coverage, for the differentiation between true and false positives 
findings. Many variant callers have been developed to reach the best accuracy 
considering these metrics, but they can’t work in regions of the genome where short 
reads cannot align uniquely (uncallable regions). The misalignment of reads on the 
reference genome can arise when reads are too short to overcome repetitious regions 
of the genome, causing the software to assign a low-quality score to the read pairs 
of the same fragment. A limitation of this process is that variant callers are not able 
to call variants in these regions, unless the quality of one of the two read mates 
could increase. Moreover, current metrics are not able to define with accuracy these 
regions, lacking in providing this information to the final customer. For this reason, 
a more accurate metric is needed to clearly report the uncallable genomic regions, 
with the prospect to improve the data analysis to possibly investigate them. This 
work aimed to improve the callability (genotypability) of the target regions for a 
more accurate data analysis and to provide a high-quality variant calling.  
Different experiments have been conducted to prove the relevance of genotypability 
for the evaluation of targeted resequencing performance. Firstly, this metric showed 
that increasing the depth of sequencing to rescue variants is not necessary at 
thresholds where genotypability reaches saturation (70X). To improve this metric 
and to evaluate the accuracy and reproducibility of results on different enrichment 
technologies for WES sample processing, the genotypability was evaluated on four 
exome platforms using three different DNA fragment lengths (short: ~200, 
medium: ~350, long: ~500 bp). Results showed that mapping quality could 
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successfully increase on all platforms extending the fragment, hence increasing the 
distance between the read pairs. The genotypability of many genes, including 
several ones associated to a clinical phenotype, could strongly improve. Moreover, 
longer libraries increased uniformity of coverage for platforms that have not been 
completely optimized for short fragments, further improving their genotypability. 
Given the relevance of the quality of data derived, especially from the extension of 
the short fragments to the medium ones, a deeper investigation was performed to 
identify a potential threshold of fragment length above which the improvement in 
genotypability was significant. On the enrichment platform producing the higher 
enrichment uniformity (Twist), the fragments above 230 bp could obtain a 
meaningful improvement of genotypability (almost 1%) and a high uniformity of 
coverage of the target. Interestingly, the extension of the DNA fragment showed a 
greater influence on genotypability in respect on the solely uniformity of coverage. 
The enhancement of genotypability for a more accurate bioinformatics analysis of 
the target regions provided at limited costs (less sequencing) the investigation of 
regions of the genome previously defined as uncallable by current NGS 
methodologies. 
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INTRODUCTION 
 
Targeted resequencing 
 
Whole exome sequencing (WES) coupled with Next-generation Sequencing (NGS) 
platforms is a methodology that allows to capture and sequence the protein-coding 
regions of the genome with unprecedented efficiency [1]. Despite Whole-Genome 
Sequencing (WGS) is considered as the most comprehensive strategy for the 
analysis of the human genome, it still presents unaffordable costs for many research 
laboratories. For this reason, WES is becoming a standard, more economic 
approach for the analysis of disease-causing genetic variations [2][3][4]. Despite 
the limited regions covered by WES (about 1% of the entire genome [5]), this 
method can perform a deeper sequencing (higher coverage levels of the target 
regions) and hence produce a large quantity of data (sequenced reads) that needs to 
be analysed through specific bioinformatics pipelines [4][6][7][8]. 
The Illumina sequencing technology can produce millions of short sequence 
information (reads) in a single run. The DNA fragments produced for the 
sequencing library can be read to yield single-end reads (only one end of the 
fragment is sequenced) or paired-end reads (both ends of the fragment are 
sequenced) [9]. After reads are generated, they are aligned to a known reference 
genome sequence (i.e. human). Alignment algorithms perform better using the 
paired-end read information, since they exploit the known distance between the 
read pairs to produce a more precise mapping to the genome (Figure 1). In some 
cases, the sequenced DNA fragment could be shorter than the sum of the lengths of 
two read pairs, producing an overlap (Figure 2). This could lead to alignment issues 
and for this reason short DNA fragments are usually sequenced using the 75 paired-
end mode (only 75 bp from both ends of the fragment are sequenced). However, 
the shorter the read, the more difficult will be its alignment to the genome. 
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Reads must be therefore long enough to be aligned unambiguously to a known 
reference sequence [10] and the depth of coverage represents the number of times 
a base in the reference is covered by an aligned read from a sequencing experiment 
[11] (Figure 3).  
Figure 2. Overlapping of sequenced read pairs.  
Figure 1. Paired-End vs. Single-Read Sequencing (Illumina). 
Retrieved 10/12/2019, from 
https://emea.illumina.com/science/technology/next-generation-
sequencing/plan-experiments/paired-end-vs-single-read.html?langsel=/it/  
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Variant calling is then performed after sequence alignment. Variations at the level 
of single nucleotides in the genome can be identified using different software, 
developed considering diverse algorithms and filtering strategies, thus leading to 
different outputs [12]. Lastly, the annotation of the identified variants is necessary 
to evaluate their biological potential consequences and hence their association to a 
variety of diseases [1]. 
 
 
  
Figure 3. Graphical visualization of a BAM file.  
The picture shows in grey colour the aligned reads present in the sequence alignment file 
(BAM). Gaussian curves on the top of the picture show the coverage values of the region. 
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Metrics for the evaluation of quality for WES enrichment technologies 
 
Commercially available WES enrichment platforms for sample processing are 
designed with the aim to target selected regions of interest (ROI) through sequence 
enrichment, which is generally accomplished through probe-target hybridization. 
This methodology can directly capture large regions of interest (such as the human 
exome, ∼30Mb) from a NGS library using complementary oligonucleotides in 
solution or array, with limited costs [13]. Currently, exome enrichment methods 
offered by vendors [14] differ in terms of enrichment efficiencies, targeted regions 
(Figure 4) and DNA input requirements [15]. Their performance is generally 
evaluated according to the depth and uniformity of coverage [16], because a 
minimum site coverage of more than 10-fold [17][18][19] is generally required to 
identify germline variants [11]. However, the average depth of coverage of the ROI 
is not indicative of the coverage of each gene/exon analysed, as some of them could 
be captured differently (or not captured at all, as shown in Figure 5) by the kits’ 
probes.  
 
 
 
Figure 4. Differences in BED coordinates.  
Genomic coordinates of exon 2 of the GZMB gene reported in the BED files provided by 
different enrichment platforms suppliers. 
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Therefore, different enrichment technologies produce different coverage levels on 
the same set of genes (Figure 6). Considering these dissimilarities, the choice of the 
more appropriate platform to use for a clinical investigation of a candidate set of 
genes is generally based on the genes’ optimal overall coverage obtained across the 
different kits. 
 
 
 
Figure 6. The difference in coverage levels for a set of genes enriched through different 
enrichment platforms.  
Percentage of each gene covered at least by 20 reads for 8 different enrichment platforms. 
Figure 5. Differences in regions covered of the same gene.  
Three exons of the same gene are covered differently using diverse enrichment 
technologies. 
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The optimal coverage for the achievement of useful data is obtained when the entire 
length of the target regions reaches the desired coverage at the expense of the off-
target rate, which is referred to as the sequencing data mapping near (~250 bp) and 
outside the target region (Figure 7). Most of the off-target sequencing is probe 
panel-specific and is usually a result of indiscriminate hybridization.  On-target and 
off-target rates are both considered in combination with the uniformity of 
enrichment (FOLD 80 penalty value) to define the efficiency of the targeted 
resequencing.  
 
 
The uniformity of coverage describes the read distribution along target regions of 
the genome and it’s calculated by the FOLD 80 penalty value, which indicates “the 
fold of additional sequencing required to ensure that 80% of the target bases achieve 
the desired average coverage”. FOLD 80 penalty is calculated as the average 
coverage on target divided by the coverage at the 80th percentile, which is the 
coverage value that lies at the 80% line of an ordered set of coverage values 
representing each sequenced base of the target. Uniformity can be improved 
reducing the coverage of over-sequenced targets and increasing the coverage of the 
target with lower sequencing, so that the amount of sequencing needed to obtain 
high-confidence data will be reduced [20] (Figure 8). Therefore, small 
Figure 7. Definition of on/near/off target.  
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improvements in uniformity can have a much larger impact on increasing the 
efficiency of the targeted resequencing.  
 
 
 
 
  
Figure 8. Uniformity of coverage (Twist [20]). 
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Data analysis: current challenges 
 
Challenges of current bioinformatic pipelines for WES data analysis are diverse, 
from the read alignment to the variant calling. Read alignment could negatively 
affect the identification of variants if the reads are not correctly assigned to their 
position along the reference genome. This problem could arise if the reads map to 
multiple locations on the reference sequence, and various strategies have been 
adopted to solve it [13]: 
• Discard the reads mapping not uniquely to the genome (this can cause an 
omission of up to 30% of mappable reads) 
• The best-match approach maps the reads choosing the location with the 
fewest mismatches (in case of more than one best match, all locations or a 
random selection is provided) 
• Report all alignments until a maximum number consented 
However, the second and the third approach could lead to a misalignment of reads, 
especially in repetitious regions of the genome. Sequence aligners assign quality 
scores to read pairs according to the uniqueness of the alignment (probability the 
read is not mapped randomly), so reads mapping to duplicated regions gain a low 
quality. However, if one of the two read mates can be mapped unambiguously they 
both may gain a high quality score [8][21][22]. 
The use of the solely depth of coverage as main quality parameter for the WES 
performance presents therefore some limitations. Indeed, high coverage levels do 
not always correspond to a high quality of read alignment, as shown in Figure 9. If 
the target region is repeated along the genome, the quality of the reads aligned there 
is low. In case a variant is present in this region, the software cannot provide a high 
confidence of call.  
For this reason, depth and uniformity of coverage cannot be considered as the main 
parameters for the evaluation of WES performances. 
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Genotypability is a metric introduced in this work which reports the “callable” and 
“uncallable” regions of the target, through the use of the gVCF (Figure 10). The 
pipeline chosen for the analysis of WES data integrates the use of the gVCF file for 
the analysis of the base calling at the level of the entire genome. While current 
pipelines use the VCF to store the high-confidence variant sites present in the 
analysed individual’s genome, the gVCF contains also the invariant sites passing 
the quality filters, allowing the distinction between a variant “not called” because 
not present in the individual’s genome and a variant “not called” because the site 
coverage and the quality of the alignment in that position do not satisfy the 
requirements of base calling. 
This value can be calculated for any region of interest (target design, RefSeq genes, 
a locus) and in this work it is used to evaluate how the DNA fragment length could 
improve the sequence alignment of genomic regions which do not satisfy the 
requirements of minimum read depth and mapping quality. 
Figure 9. Region of the genome highly covered but with low mapping quality. 
Graphic visualization of a BAM file. Colour of reads indicates the mappinq quality: 
white = low quality mapping; grey = high quality mapping. 
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Through the use of gVCF it is possible to rescue homozygous reference variants for 
the data analysis, but unravelling the variants present in repetitious regions of the 
genome is still difficult using short reads. For this reason, an approach to improve 
this metric is needed.  
  
Figure 10. Differences between a VCF and a gVCF.  
gVCF reports not only the variant sites in the genome, but also the invariant one which can 
satisfy the requirements of minimum mapping quality and depth of coverage. 
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DNA fragment length 
 
 
 
WES library preparation protocols set the DNA fragment size to the average exon 
length, which is 170 bp in the human genome [21][22][23]. Short (< 100 bp) paired-
end reads are generated to avoid the overlap of read pairs, but this fragment length 
is often shorter than duplicated regions. Furthermore, library preparation protocols 
often start from very low quantities of material (nanograms to picograms) [24], 
limiting the amount of DNA and consequently the number of unique fragments that 
can be produced. For this reason, 2 × 75 sequencing requires double the number of 
fragments to produce the expected depth of coverage that can be achieved by 2 × 
150 sequencing. More amplification is therefore necessary, producing more PCR 
duplicates that must be removed during downstream data analysis, thus limiting the 
depth of coverage at target regions [25]. 
Considering the challenges due to the difficult alignment of short reads to 
repetitious regions of the genome, this approach aims to increase the standard DNA 
fragment size to allow longer fragments to extend beyond exonic regions to reach 
introns, which are under less selection pressure than protein coding sequences but 
Figure 11. Constraints in genome evolution.  
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still retain conserved polymorphisms [23] (Figure 11). This means that introns are 
still evolutionary conserved (as they are important in regulating gene expression), 
but with a greater variability in respect of exons. Therefore, reads that cannot 
uniquely align in repetitious exonic regions could better align on flanking intronic 
regions, that may not conserve the same repetition. In this way, the higher quality 
of mapping obtained for the read mapping outside of repetitious regions can be 
transferred to its mate, allowing the identification of variants that could be 
otherwise discarded, due to poor-mapping (Figure 12). 
 
 
 
  
Figure 12. Alignment of read pairs and extension of the DNA fragment.  
Transfer of high-quality of read alignment between read pairs through the extension 
of the DNA fragment size. 
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The PANINI project 
 
Considering the implications of targeted analysis for diagnosis and therapies, the 
European project "Physical Activity and Nutrition INfluences In ageing" (PANINI) 
aimed to develop a policy document to promote healthy ageing in Europe [26]. In 
particular, the project addressed the need to identify the genetic markers responsible 
for ageing diseases and nutritional responses, to drive personalized treatments to 
older adults. The application of a bioinformatics pipeline such as the one here 
developed could provide the more accurate analysis for this type of clinical 
employment. 
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AIM OF THE THESIS 
 
Variant calling on human DNA-seq samples presents limitations due to possible 
misalignments of short reads on the reference genome and incomplete quality 
metrics to define the accuracy of bioinformatics data. The aim of the thesis was to 
improve the accuracy of data produced by targeted resequencing workflows 
through the enhancement of the genotypability of the target regions, for a more 
precise variant calling and a more accurate investigation of the uncallable regions 
of the genome.  
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MATERIALS AND METHODS 
 
Sample processing 
 
Genotypability evaluation on a single individual 
 
The WES analysis was performed on data derived from an individual processed by 
the wet-lab using the Human Core Exome Kit + RefSeq V1 enrichment platform 
(Twist), producing a DNA fragment size based on the manufacturers’ 
recommendations. 
 
Genotypability evaluation on different enrichment technologies and DNA fragment 
lengths 
 
The WES analysis was performed on data derived from three unrelated individuals. 
Samples were processed using four different enrichment platforms: xGen Exome 
Research Panel V1 (IDT), SeqCap EZ MedExome (Roche), SureSelect Human All 
Exon V6 (Agilent), and the Human Core Exome Kit + RefSeq V1 (Twist). The wet-
lab produced three different DNA fragment lengths for each sample: short 
fragments based on the manufacturers’ recommendations (IDT = 150 bp, Roche, 
Agilent and Twist = 200 bp), medium fragments (expected length ~350 bp), and 
long fragments (expected length ~500 bp).  
 
Genotypability evaluation on a variable set of DNA fragments 
 
The WES analysis was performed on data derived from 27 individuals processed 
by the wet-lab using the Human Core Exome Kit + RefSeq V1 enrichment platform 
(Twist), which produced a variable set of DNA fragments sizes from ~200 to ~350 
bp. 
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Bioinformatics pipeline 
 
Preprocessing of raw reads and sequence alignment 
 
All individuals were sequenced on an Illumina instrument in 75 bp paired-end mode 
for the short libraries (~200 bp) and in 150 bp paired-end mode for the other DNA 
fragment lengths. All samples were analysed performing a preprocessing of raw 
reads and the alignment to the reference genome sequence. 
The preprocessing pipeline was based on a set of available tools as described below 
(Figure 13).  
 
 
 
 
Initial FASTQ files were quality controlled using FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Low quality 
nucleotides have been trimmed using sickle v1.33 
Figure 13. Pipeline for preprocessing of raw reads and sequence alignment.  
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(https://github.com/najoshi/sickle) and adaptors were removed using scythe v0.991 
(https://github.com/vsbuffalo/scythe).  
 
 
Reads were then aligned to the reference human genome sequence (GRCh38/hg38) 
using BWA-MEM v0.7.15 (https://arxiv.org/abs/1303.3997). BWA is a fast and 
memory-efficient read aligner widely used for WES. The SAM output file was 
converted into a sorted BAM file using SAMtools. Overlapping regions of the BAM 
file were clipped using BamUtil v1.4.14 to avoid counting multiple reads 
representing the same fragment. The BAM files were processed by local 
realignment around insertion–deletion sites, duplicate marking and recalibration 
using Genome Analysis Toolkit v4.0.2.1 [27].  
 
#FastQC 
 
fastqc sample.read1.fastq.gz sample.read2.fastq.gz -o fastqc/ 
 
#Trimming 
 
sickle pe -g -t sanger \ 
        -f <( scythe -a adapters.file -q sanger sample.read1.fastq.gz } ) \ 
        -r <( scythe -a adapters.file -q sanger sample.read2.fastq.gz } ) \ 
        -o trimmed1.fastq.gz -p trimmed2.fastq.gz -s /dev/null; 
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Downsampling for a N theoretical X-fold coverage on the target design was 
calculated subsampling the required number of fragments (calculated as: (N * 
design length) / (read length * 2)) using seqtk (https://github.com/lh3/seqtk). 
Downsampling on the mapped coverage was generated by sub-sampling the full 
dataset using sambamba v0.6.7 – https://github.com/biod/sambamba –).  
#Alignment 
 
my $RG = '"@RG' 
      . qq|\tID:$ID\tPU:lane\tLB:$NAME\tSM:$NAME\tCN:CGF-ddlab\tPL:ILLUMINA"|; 
 
bwa mem -R $RG -t 16 Homo_sapiens_assembly38.fasta trimmed*fastq.gz | 
samtools sort --threads 4 -m 5G - -o start_sorted.bam 
 
sambamba index --nthreads= 20 start_sorted.bam 
 
#Clipping 
 
bam clipOverlap --in start_sorted.bam --out start_sorted.clipped.bam 
 
#Duplicate marking 
 
java -jar gatk.jar MarkDuplicates -I start_sorted.clipped.bam -O alignment.rg.bam -M 
duplicates.txt --REMOVE_DUPLICATES true --VALIDATION_STRINGENCY SILENT --
CREATE_INDEX true 
 
#Base recalibrator 
 
java -jar gatk.jar BaseRecalibrator -I alignment.rg.bam -R 
Homo_sapiens_assembly38.fasta --use-original-qualities --knownSites dbsnp.vcf --
knownSites mills.vcf -O recal_data.table 
 
java -jar gatk.jar ApplyBQSR -R Homo_sapiens_assembly38.fasta -I alignment.rg.bam 
-bsqr recal_data.table -O alignment.rg.recalibrated.bam --static-quantized-quals 10 --
static-quantized-quals 20 --static-quantized-quals 30 --add-output-sam-program-
record --create-output-bam-md5 --use-original-qualities 
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Metrics collection 
  
Insert sizes were calculated after read alignment, measuring the distance of the two 
mates mapped on the genome using CollectInsertSize by Picard v2.17.10 
(http://broadinstitute.github.io/picard/). CollectHsMetrics by Picard was used to 
calculate fold enrichment and FOLD 80 penalty values to determine enrichment 
quality. For each sample, the near target length was defined as the “average length 
of the DNA fragments” padding the on-target region. All WES performance 
parameters were calculated both on the design of each platform and on the standard 
dataset of RefSeq genes. 
 
#Downsampling for theoretical coverage 
 
seqtk sample -s100 sample.read1.fastq.gz $number_of_fragments 
seqtk sample -s100 sample.read2.fastq.gz $number_of_fragments 
 
#Downsampling for mapped coverage 
 
my $ratio = $target_mapped_coverage / $real_mapped_coverage 
sambamba view -h -t 30 -s $ratio -f bam alignment.rg.recalibrated.bam -o 
downsampled.bam 
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Genotypability metric 
  
I then used CallableLoci in GATK v3.8 to identify callable regions of the target 
(genotypability), with minimum read depths of 3 and 10.  
 
#Insert size collection 
 
java -jar gatk.jar CollectInsertSizeMetrics -I alignment.rg.recalibrated.bam -H 
alignment.rg.recalibrated.hist.pdf -O alignment.rg.recalibrated.output -AS true --
VALIDATION_STRINGENCY SILENT 
 
#Mapping statistics 
 
samtools flagstat alignment.rg.recalibrated.bam > flagstat_recal 
 
#ON/NEAR/OFF target statistics on design and RefSeq 
 
java -jar GenomeAnalysisTK.jar CollectHsMetrics --INPUT 
alignment.rg.recalibrated.bam --OUTPUT design.HsMetrics.txt -R 
Homo_sapiens_assembly38.fasta \ 
        --BAIT_INTERVALS design.bed.interval --TARGET_INTERVALS design.bed.interval 
\ 
        --PER_TARGET_COVERAGE design.PER_TARGET_COVERAGE.txt --
PER_BASE_COVERAGE design.PER_BASE_COVERAGE.txt --
VALIDATION_STRINGENCY=SILENT \ 
        --NEAR_DISTANCE insert_length 
 
java -jar GenomeAnalysisTK.jar CollectHsMetrics --INPUT 
alignment.rg.recalibrated.bam --OUTPUT RefSeq.HsMetrics.txt -R 
Homo_sapiens_assembly38.fasta \ 
        --BAIT_INTERVALS RefSeq.bed.interval --TARGET_INTERVALS RefSeq.bed.interval 
\ 
        --PER_TARGET_COVERAGE RefSeq.PER_TARGET_COVERAGE.txt --
PER_BASE_COVERAGE RefSeq.PER_BASE_COVERAGE.txt --
VALIDATION_STRINGENCY=SILENT \ 
        --NEAR_DISTANCE insert_length 
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CallableLoci produces a BED file with the callable status covering each base and 
a summary table of callable status per count of all examined bases (Figure 14).  
 
 
The callable states of the genomic intervals are summarised in Figure 15. 
 
 
#CallableLoci 
 
java -jar GenomeAnalysisTK.jar -T CallableLoci -R Homo_sapiens_assembly38.fasta -I 
alignment.rg.recalibrated.bam -summary callable_table.txt -o callable_status.bed 
 
java -jar GenomeAnalysisTK.jar -T CallableLoci -R Homo_sapiens_assembly38.fasta -I 
alignment.rg.recalibrated.bam -minDepth 10 -summary callable_table.txt -o 
callable_status_DP10.bed 
Figure 14. BED file e summary table produced by CallableLoci.  
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bedtools coverage was used to calculate the coverage of the target regions at several 
coverage levels (1X, 5X, 10X, 20X, 30X) and the genotypability of the target at 
read depths of 3 (% PASS) and 10 (% PASS RD>10). Through a specific script 
(geneCoverage.pl), the information of the depth of coverage and the number of 
bases at that depth from the design.alignment.rg.recalibrated.capture.hist.coverage.gz 
and the RefSeq.alignment.rg.recalibrated.capture.hist.coverage.gz files were calculated 
for: 
• each region of the target design/RefSeq; 
• each gene of the target design/RefSeq; 
• all the target design/RefSeq. 
 
Figure 15. Callable states of CallableLoci.  
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Then, the output files design.alignment.rg.recalibrated-callable.bed and 
RefSeq.alignment.rg.recalibrated-callable.bed were used for the calculation of the 
genotypability of the target. The number of CALLABLE bases covered for each 
region of the target design/RefSeq was extracted from the two files and transformed 
into a percentage value. 
 
#Region coverage calculations 
 
# region coverage for design 
 
bedtools coverage -hist  
-abam alignment.rg.recalibrated.bam \ 
-b design.bed | gzip > 
design.alignment.rg.recalibrated.capture.hist.coverage.gz 
 
bedtools coverage -hist  
-a callable.bed \ 
-b design.bed > design.alignment.rg.recalibrated-callable.bed 
 
bedtools coverage -hist  
-a callable_DP10.bed \ 
-b design.bed > design.alignment.rg.recalibrated-callable_DP10.bed 
 
# region coverage for RefSeq 
 
bedtools coverage -hist  
-abam alignment.rg.recalibrated.bam \ 
-b RefSeq.bed | gzip > 
RefSeq.alignment.rg.recalibrated.capture.hist.coverage.gz 
 
bedtools coverage -hist  
-a callable.bed \ 
-b RefSeq.bed > RefSeq.alignment.rg.recalibrated-callable.bed 
 
bedtools coverage -hist  
-a callable_DP10.bed \ 
-b RefSeq.bed > RefSeq.alignment.rg.recalibrated-callable_DP10.bed 
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Variant calling 
 
Variant calling was performed producing gVCF files through the GATK 
HaplotypeCaller v4.1.2.0 software. It calls germline Single Nucleotide Variations 
and indels via a local re-assembly of haplotypes.  
 
Variant recalibration was performed to assign a well-calibrated probability to each 
variant call in a call set. This enabled the generation of highly accurate call sets by 
filtering based on this single estimate for the accuracy of each call. 
#Genotypability and coverage statistics 
 
#For design 
 
geneCoverage.pl          
design.alignment.rg.recalibrated.capture.hist.coverage.gz \ 
design.alignment.rg.recalibrated-callable.bed \ 
design.alignment.rg.recalibrated-callable_DP10.bed 
 
#For RefSeq 
 
geneCoverage.pl  
RefSeq.alignment.rg.recalibrated.capture.hist.coverage.gz \ 
RefSeq.alignment.rg.recalibrated-callable.bed \ 
RefSeq.alignment.rg.recalibrated-callable_DP10.bed 
 
#Variant calling 
 
java -jar gatk.jar HaplotypeCaller -R Homo_sapiens_assembly38.fasta -I 
alignment.rg.recalibrated.bam --dbsnp dbsnp.vcf -ERC GVCF --output snps.raw.g.vcf -
-standard-min-confidence-threshold-for-calling 30.0 --force-active true 
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As a final step, a hard-filtering was performed on variant calls based on certain 
criteria. In particular, for SNPs: 
• QD (Quality by Depth) was set to < 2.0 
• MQ (RMS Mapping Quality) was set to < 40 
• FS (Fisher Strand) was set to > 60.0 
• SOR (Strand Odds Ratio) was set to > 3.0 
• MQRankSum (MappingQualityRankSumTest) was set to < -12.5 
• ReadPosRankSum was set to < -8.0 
#Variant recalibration 
 
java -jar gatk.jar GenotypeGVCFs  -R Homo_sapiens_assembly38.fasta -V 
snps.raw.g.vcf -G StandardAnnotation -O complete.raw.variants.vcf 
 
java -jar gatk.jar VariantRecalibrator -V complete.raw.variants.vcf -O 
INDEL.recalibration --tranches-file INDEL.tranches --trust-all-polymorphic \ 
       -tranche 100.0 -tranche 99.9 -tranche 99.0 -tranche 90.0 \ 
        -an QD -an DP -an FS -an SOR -an MQRankSum -an ReadPosRankSum \ 
        -mode INDEL --max-gaussians 4 -R $REF \ 
        -resource:mills,known=false,training=true,truth=true,prior=12 mills.vcf \ 
        -resource:axiomPoly,known=false,training=true,truth=false,prior=10 axiom.vcf \ 
        -resource:dbsnp,known=true,training=false,truth=false,prior=2 dbsnp.vcf 
 
java -jar gatk.jar VariantRecalibrator -V complete.raw.variants.vcf -O 
SNPS.recalibration --tranches-file SNPS.tranches --trust-all-polymorphic \ 
        -tranche 100.0 -tranche 99.9 -tranche 99.0 -tranche 90.0 \ 
        -an DP -an QD -an FS -an SOR -an MQ -an MQRankSum -an ReadPosRankSum -
mode SNP --max-gaussians 6 \ 
        -resource:hapmap,known=false,training=true,truth=true,prior=15 hapmap.vcf \ 
        -resource:omni,known=false,training=true,truth=true,prior=12 omni.vcf \ 
        -resource:1000G,known=false,training=true,truth=false,prior=10 phase1.vcf \ 
        -resource:dbsnp,known=true,training=false,truth=false,prior=7 dbsnp.vcf 
 
java -jar gatk.jar ApplyVQSR -O indel.recalibrated.vcf -V complete.raw.variants.vcf --
recal-file INDEL.recalibration --tranches-file INDEL.tranches \ 
        --truth-sensitivity-filter-level 99 --create-output-variant-index true -mode INDEL 
 
java -jar gatk.jar ApplyVQSR -O variants.recalibrated.vcf -V indel.recalibrated.vcf --
recal-file SNPS.recalibration --tranches-file SNPS.tranches \ 
        --truth-sensitivity-filter-level 99 --create-output-variant-index true -mode SNP 
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as specified by the GATK Best Practices. 
While, for the indels, parameters were set as following: 
• QD (Quality by Depth) was set to < 2.0 
• FS (Fisher Strand) was set to > 200.0 
• ReadPosRankSum was set to < -20.0 
as specified by the GATK Best Practices. 
 
 
 
Datasets 
 
The RefSeq database (release 82) was downloaded from the UCSC Genome Table 
Browser (http://genome.ucsc.edu/). Online Mendelian Inheritance in Man (OMIM) 
#Variant filtering 
 
java -jar gatk.jar SelectVariants --select-type-to-include SNP --output raw_snps.vcf -V 
complete.raw.variants.vcf 
 
java -jar gatk.jar SelectVariants --select-type-to-exclude SNP --output raw_indels.vcf -
V complete.raw.variants.vcf 
 
java -jar gatk.jar VariantFiltration -R Homo_sapiens_assembly38.fasta -V 
raw_snps.vcf \ 
                --filter-expression "QD < 2.0 || MQ < 40.0 || FS > 60.0 || SOR > 3.0 || 
MQRankSum < -12.5 || ReadPosRankSum < -8.0" \ 
                --filter-name "Broad_SNP_filter" -O  raw_filtered_snps.vcf 
 
java -jar gatk.jar VariantFiltration -R Homo_sapiens_assembly38.fasta -V 
raw_indels.vcf \ 
                --filter-expression "QD < 2.0 || FS > 200.0 || ReadPosRankSum < -20.0" \ 
                --filter-name "Broad_indel_Filter" -O raw_filtered_indels.vcf 
 
java -jar gatk.jar MergeVcfs -I raw_filtered_snps.vcf -I raw_filtered_indels.vcf -O 
variants.filtered.vcf 
 
java -jar gatk.jar SelectVariants -R Homo_sapiens_assembly38.fasta --variant 
variants.filtered.vcf.gz --exclude-filtered -O variants.selected.vcf 
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genes associated with a clinical phenotype were downloaded from the OMIM 
website (https://www.omim.org/, release 15-05-2018). 
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RESULTS 
 
The genotypability metric and the depth of coverage 
 
I initially performed an evaluation to assess the relevance of the genotypability 
metric in respect of the solely depth of coverage. Whole Exome Sequencing was 
performed on a representative sample (VRXX) processed by the wet-lab using the 
Twist Human Exome Core plus RefSeq v.1 Reagent kit. The expected mapped 
coverage for this experiment was of 200X, meaning that the entire region of interest 
could be read on average 200 times. From the initial set of sequenced reads, I 
produced downsampled BAM files (with an average X-fold coverage of 10–190) 
on the target design, to evaluate the percentage of the ROI covered by a minimum 
number of reads (1,5,10,20,30) at different coverage levels (10-200X). The same 
evaluation was performed for the genotypability (callability) of the target. 
Results showed that the percentage of the target covered by at least 10 reads, 
augmented significantly between 10-140X and then reached saturation (Table 1). 
In a similar way, the %20X value increased continuously until reaching saturation 
at 170X, whereas the %30X could not reach saturation even at 200X mapped 
coverage. Considering these results, in order to reach a substantial coverage along 
all the target regions, the sequencing depth should be greatly increased. However, 
the genotypability of the target calculated using the standard requirements of the 
GATK workflow (read depth >3) reached saturation at 70X mapped coverage 
(Figure 16). Genotypability at a minimum read depth of 10, the coverage threshold 
suggested by clinical guidelines for the variant identification in genetics 
laboratories, instead reached saturation at higher coverage levels (130X). 
These results showed that increasing the sequencing coverage above 70X could not 
lead to a better callability of the target regions, if considering the standard 
requirements of GATK. Thus, coverage levels commonly considered too low for 
variants identification instead could be potentially adequate for the bioinformatics 
data analysis. For clinical settings, further sequencing coverage could be required 
based on the laboratory’s needs.  
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Mapped 
Coverage 
%1X %5X %10X %20X %30X % PASS 
% PASS 
RD>10 
10 99.39 86.23 49.22 4.48 0.59 87.44 45.96 
20 99.86 97.46 87.66 48.19 13.78 94.23 83.53 
30 99.90 99.19 95.38 77.46 47.97 95.18 91.10 
40 99.91 99.64 97.81 88.34 70.72 95.43 93.50 
50 99.92 99.80 98.88 93.16 82.58 95.49 94.54 
60 99.92 99.85 99.38 95.65 88.67 95.51 95.03 
70 99.92 99.88 99.62 97.11 92.12 95.53 95.26 
80 99.92 99.89 99.74 98.04 94.30 95.53 95.38 
90 99.92 99.90 99.81 98.63 95.77 95.53 95.44 
100 99.92 99.90 99.84 99.03 96.78 95.54 95.48 
110 99.92 99.90 99.86 99.30 97.53 95.54 95.50 
120 99.92 99.91 99.87 99.49 98.11 95.54 95.51 
130 99.92 99.91 99.88 99.60 98.53 95.54 95.52 
140 99.92 99.91 99.89 99.69 98.85 95.54 95.52 
150 99.92 99.91 99.89 99.74 99.09 95.54 95.53 
160 99.92 99.91 99.90 99.78 99.28 95.54 95.53 
170 99.92 99.91 99.90 99.81 99.41 95.54 95.53 
180 99.92 99.91 99.90 99.83 99.52 95.54 95.53 
190 99.92 99.91 99.90 99.84 99.60 95.54 95.54 
200 99.92 99.91 99.91 99.86 99.70 95.54 95.54 
 
Table 1. Downsampled mapped coverage.  
Metrics were calculated on 10–200X downsampled sets, including mapped coverage on 
the target, percentage of the target covered by at least 1, 5, 10, 20 and 30 reads, and 
percentage of callable bases on the target for standard read depth (>3) and read depth > 
10. 
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Figure 16. Tendency of percentage of covered target and genotypability at different coverage 
levels.  
Percentage of the target covered by at least 1, 5, 10, 20 and 30 reads (blue lines) and percentage of 
callable bases on the target for standard read depth (>3) and read depth > 10 (red lines) is shown. 
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The pipeline for the performance evaluation of WES 
 
The in-house bioinformatics pipeline used for the data analysis was developed 
considering the relevance of the genotypability metric revealed by the previous 
experiment. I integrated the Genome Analysis Toolkit Best Practices Workflow (for 
Germline short variant discovery) with two available Quality Control Tools, for the 
analysis of WES performance (Figure 17). The first tool, BamUtil v1.4.14 through 
the option clipOverlap, performed the clipping of overlapping read pairs from the 
BAM file to avoid counting multiple reads representing the same fragment. The 
addition of this step to the standard pipeline (before marking the duplicates in the 
BAM file and recalibrating the base quality scores) was necessary to prevent the 
identification of false positives in the downstream analysis. Statistics on the 
overlaps were produced to monitor the number of overlapping pairs and the average 
number of reference bases overlapped. Then, I used the CallableLoci tool (GATK 
v3.8) on the analysis-ready BAM file to identify the regions of the target considered 
as “callable” (the sites for which the requirements of minimum read depth and 
minimum quality of mapping were satisfied). This tool considers the coverage at 
each locus and emits an interval BED file that partitions the genome into different 
callable states. Only PASS states were kept for the calculation of genotypability. 
The BED file was produced for two minimum read depths: 3 and 10. When the 
BED file was produced by CallableLoci, it was filtered for CALLABLE regions 
only, followed by an analysis of regions coverage. I used the option bedtools 
coverage (v2.19.1) to compute both the depth and breadth of coverage of the target 
regions (the target design and the RefSeq genes).  
I then collected all the statistics produced for the evaluation of WES performance:  
• percentage of the target (for both the design and RefSeq genes) covered by 
at least 1, 5, 10, 20, 30 reads (%1X, %5X, %10X, %20X, %30X); 
• the genotypability of the target at read depths of 3 (% PASS) and 10 (% 
PASS RD>10); 
• the average insert size; 
• the number of mapped deduplicated reads; 
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• the percentage of duplicates; 
• the percentage of on/near/off target bases sequenced; 
• the fold enrichment; 
• the fold-80 penalty value 
• the number of fragments produced by each experiment. 
 
All these values were used for the evaluation of the effects of the DNA fragment 
extension on the different enrichment platforms. 
 
 
 
  
Figure 17. Integration of quality control steps with the standard GATK pipeline.  
DC=Depth of Coverage. 
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WES performances on 3 different DNA fragment lengths 
 
I assessed the performance of short (∼200 bp), medium (∼350 bp) and long (∼500 
bp) DNA fragments on four major commercial exome enrichment platforms 
produced by IDT, Roche, Agilent and Twist. For each platform, the wet-lab 
generated the libraries from the genomic DNA of three unrelated individuals 
(NA12891, NA12982 and VR00), enriched according to the manufacturers’ 
instructions and sequenced on an Illumina HiSeq3000 instrument.  
For the initial dataset of 36 samples, statistics were calculated considering: the total 
number of sequenced fragments, the GC percentage, the theoretical coverage, the 
mapped deduplicated reads, the average insert size, the percentage of duplicates and 
the mapped coverage (Table 2).  
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ID Sequenced 
fragments 
GC% Design length Theoretical 
coverage (X) 
Mapped 
deduplicated 
fragments 
Average 
insert size 
% 
Duplicates 
Mapped 
coverage 
(X) 
NA12891_IDT-S 41,735,851 52 38,871,205 161.05 34,798,458 170.56 14.76 78.02 
NA12891_IDT-M 31,721,147 51 38,871,205 244.82 27,295,886 338.36 12.57 95.92 
NA12891_IDT-L 35,056,454 52 38,871,205 270.56 29,048,970 419.16 15.62 97.28 
NA12891_Roche-S 69,139,041 48 47,007,710 220.62 53,971,159 250.20 19.09 92.04 
NA12891_Roche-M 30,139,859 48 47,007,710 192.35 25,187,948 352.58 14.76 73.15 
NA12891_Roche-L 37,597,648 48 47,007,710 239.95 31,408,182 475.51 14.05 81.22 
NA12891_Agilent-S 69,997,150 51 60,448,148 173.70 56,394,632 267.56 16.11 85.70 
NA12891_Agilent-M 43,377,376 50 60,448,148 215.28 36,041,040 350.30 15.74 96.23 
NA12891_Agilent-L 62,476,876 49 60,448,148 310.07 50,712,887 438.63 15.70 122.77 
NA12891_Twist-S 62,145,209 52 36,715,240 253.89 53,990,842 211.43 9.24 106.91 
NA12891_Twist-M 45,101,242 49 36,715,240 368.52 37,418,907 390.49 14.57 106.47 
NA12891_Twist-L 56,814,853 49 36,715,240 464.23 48,349,215 389.09 12.24 136.39 
NA12892_IDT-S 39,279,677 52 38,871,205 151.58 33,418,710 174.23 12.97 74.92 
NA12892_IDT-M 29,737,235 51 38,871,205 229.51 25,829,978 340.75 11.40 90.66 
NA12892_IDT-L 31,442,649 52 38,871,205 242.67 26,557,527 422.28 13.69 88.66 
NA12892_Roche-S 63,475,661 48 47,007,710 202.55 51,637,279 263.49 15.33 86.49 
NA12892_Roche-M 25,113,466 48 47,007,710 160.27 21,737,831 353.95 11.70 63.42 
NA12892_Roche-L 35,647,295 48 47,007,710 227.50 29,755,564 483.46 13.90 76.69 
NA12892_Agilent-S 63,367,878 50 60,448,148 157.25 50,458,064 270.99 16.64 76.08 
NA12892_Agilent-M 38,379,719 50 60,448,148 190.48 32,736,504 357.00 13.32 87.30 
NA12892_Agilent-L 59,863,365 49 60,448,148 297.10 49,779,709 446.38 13.80 117.87 
NA12892_Twist-S 58,556,655 52 36,715,240 239.23 51,774,402 207.55 7.76 102.74 
NA12892_Twist-M 53,142,446 49 36,715,240 434.23 44,835,844 360.36 13.57 131.09 
NA12892_Twist-L 53,633,893 49 36,715,240 438.24 46,784,910 411.80 9.39 130.16 
VR00_IDT-S 43,858,514 52 38,871,205 169.25 36,430,811 170.05 14.88 81.28 
VR00_IDT-M 30,647,544 51 38,871,205 236.53 26,574,858 343.45 11.82 92.66 
VR00_IDT-L 28,719,060 51 38,871,205 221.65 24,489,849 429.35 13.02 80.87 
VR00_Roche-S 69,341,641 47 47,007,710 221.27 55,349,772 262.24 16.77 80.89 
VR00_Roche-M 25,769,903 48 47,007,710 164.46 22,210,538 361.45 11.86 64.00 
VR00_Roche-L 37,393,464 47 47,007,710 238.64 31,375,345 482.07 13.60 80.81 
VR00_Agilent-S 63,423,698 51 60,448,148 157.38 51,058,660 265.11 17.83 77.59 
VR00_Agilent-M 37,984,977 50 60,448,148 188.52 31,756,515 354.10 15.15 84.83 
VR00_Agilent-L 34,450,041 49 60,448,148 170.97 28,964,914 439.13 13.13 69.93 
VR00_Twist-S 58,092,508 52 36,715,240 237.34 51,158,376 209.79 8.01 101.11 
VR00_Twist-M 49,286,947 49 36,715,240 402.72 42,067,556 360.41 12.36 121.92 
VR00_Twist-L 53,025,771 48 36,715,240 433.27 46,216,132 400.91 9.92 128.25 
 
Table 2. WES initial dataset. 
For each replicate, platform and DNA fragment length combination, the number of 
sequenced fragments, percentage GC content, theoretical coverage, number of mapped 
fragments without duplicates, average insert size, percentage of reads marked as 
duplicates and mapped coverage on the target are shown. DNA fragment lengths: S = 
short, M = medium, L = long. 
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Figure 18. Theoretical and mapped coverage. 
For each replicate, platform and DNA fragment length, theoretical coverage and mapped 
coverage on the target are plotted. 
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Figure 19. Duplicates rate. 
For each replicate, platform and DNA fragment length, the duplicates rate is plotted. 
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The dataset showed many differences at the level of fragments produced and 
consequently in the number of mapped deduplicated reads. Theoretical coverage 
varied from 151X to 464X, and this was reflected in the mapped coverage (63-
136X) (Figure 18). The percentage of duplicates (reads sequenced from the same 
fragment) was also very variable (7-19%) (Figure 19). To avoid a biased 
comparison of statistics values, due to the difference in coverage levels and target 
regions considered, the dataset was firstly aggregated by the mean of the three 
independent experiments (VR00, NA12891, NA12892), and then subdivided in 
normalized datasets (Figure 20). These were used to evaluate WES performances 
for each combination of DNA fragment length and enrichment platform at different 
conditions. 
 
 
  
Figure 20. Different datasets used for the calculation of WES performances. 
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The 140X dataset 
 
From the initial dataset of sequenced reads representing each sample, I produced 
downsampled BAM files with a 140 theoretical X-fold coverage (the maximum 
theoretical coverage value obtained by all the platforms) on the target design (Table 
3). The theoretical coverage is a computed coverage based on randomly subsampled 
sequenced reads, whose amount is set considering both the length of the reads and 
the length of the target region. Theoretical coverage allows the evaluation of: 
• the on/near/off target rate, as the subsampled reads are randomly selected 
considering the entire genome 
• the fold enrichment and the FOLD 80 penalty, which both provide 
information about the read distribution 
• the percentage of duplicates, which are calculated and removed after 
mapping the reads on the target region  
 
The achieved average insert sizes were firstly evaluated, as these values were used 
for the calculation of the near-target rate. The short and medium fragment lengths 
obtained were as expected, whereas the long fragments were often shorter than 
anticipated (398–480 bp). Then, for each combination of enrichment platform and 
DNA fragment length, the 140X dataset allowed the estimation of the near and off 
target rate obtained. The number of bases sequenced near the target augmented with 
the increase of the DNA fragment size, whereas the off-target rate showed different 
trends between the platforms. The evaluation of the number of duplicates showed 
that it was consistently higher using the short DNA fragments for all platforms (12-
15%) except Twist, which had almost comparable values for the short and medium 
size (~5%). The variability in the number of duplicates and in the near/off-target 
rates determined a difference in the mapped coverage obtained, which could affect 
the evaluation of other important statistics values such as the genotypability and the 
enrichment uniformity. For this reason, a normalization on the mapped coverage 
was conducted. 
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Table 3. The 140X dataset.  
For each platform and DNA fragment length combination, the 140 theoretical X-fold 
coverage is shown for the target design dataset (mean of the three independent 
experiments). The columns show the average insert size, percentage of reads marked as 
duplicates, mapped coverage on the target, percentage of the target covered by at least 1, 
5, 10, 20 and 30 reads, percentage of callable bases on the target for standard read depth 
(>3) and read depth >10, percentage of bases on/near/off target, fold enrichment and 
FOLD 80 base penalty. DNA fragment lengths: S = short, M = medium, L = long. 
 
  
ID Average 
insert 
size 
% 
Duplicates 
Mapped 
coverage 
(X) 
%1X %5X %10X %20X %30X % 
PASS 
% 
PASS 
RD>1
0 
% ON 
TARGET 
% NEAR 
TARGET 
% OFF 
TARGET 
Fold 
enrichment 
FOLD 80 
penalty 
IDT-S 171.61 12.61 69.38 99.82 99.77 99.61 98.14 92.96 96.81 96.66 60.36 29.42 10.22 50.01 1.60 
IDT -M 340.85 7.39 57.92 99.81 99.64 98.84 92.37 79.64 97.58 96.72 48.95 40.63 10.43 40.56 1.95 
IDT -L 423.60 8.60 54.28 99.80 99.32 97.01 85.53 70.18 97.39 94.83 45.15 44.10 10.75 37.41 2.28 
Roche-S 258.64 11.81 60.10 99.86 99.36 98.33 93.53 83.01 96.17 95.02 51.86 18.13 30.01 35.50 1.89 
Roche-M 355.99 10.60 55.76 99.83 99.27 98.03 91.86 79.02 96.90 95.53 49.33 38.52 12.14 33.77 1.90 
Roche-L 480.35 8.75 50.31 99.80 99.11 97.37 87.91 71.05 96.79 94.84 42.28 36.04 21.68 28.94 2.02 
Agilent-S 267.89 14.89 70.25 99.79 99.33 98.36 94.21 85.84 95.23 94.22 61.57 21.20 17.23 32.85 2.04 
Agilent-M 353.80 10.88 66.15 99.75 99.33 98.49 94.48 85.58 96.27 95.40 57.04 26.17 16.79 30.44 1.96 
Agilent-L 441.38 11.48 58.31 99.74 99.16 97.73 90.82 78.15 96.13 94.62 50.92 36.96 12.13 27.17 2.06 
Twist-S 209.67 5.10 61.80 99.86 99.78 99.33 95.85 89.38 95.51 95.06 52.23 33.16 14.61 45.77 1.59 
Twist-M 368.28 5.26 46.41 99.82 99.71 99.21 94.96 83.24 96.57 96.06 38.92 45.65 15.43 34.11 1.47 
Twist-L 398.16 3.60 45.17 99.82 99.69 99.05 94.00 80.94 96.56 95.90 37.24 47.04 15.72 32.63 1.51 
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The 80X dataset (on design) 
 
I produced downsampled BAM files with a 80X-fold mapped coverage (the 
maximum mapped coverage value obtained by all the platforms) on the target 
design region (Table 4). The mapped coverage was calculated as the real average 
coverage obtained on the ROI, excluding the duplicates. This dataset focused only 
on the reads mapping on the design region, as everything mapping near and off the 
expected captured region was not intended to be analysed. As parameters for 
comparison I considered: coverage of the target at different thresholds (1X, 5X, 
10X, 20X, 30X), genotypability (% PASS and % PASS RD>10), the fold 
enrichment and the FOLD 80 values. I evaluated the enrichment uniformity of each 
DNA fragment/enrichment platform combination obtained using the FOLD 80 
penalty value (the fold over-coverage necessary to raise 80% of bases to the mean 
coverage level in those targets). The increase of the DNA fragments influenced the 
uniformity of enrichment: longer fragments decreased the FOLD 80 value in one 
platform (Twist), while in two others increased (IDT and Roche). The 
genotypability for each platform improved for the medium and long DNA 
fragments for both % PASS and % PASS RD>10 values. 
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ID Mapped 
coverage 
(X) 
%1X %5X %10X %20X %30X % PASS % PASS 
RD>10 
Fold 
enrichment 
FOLD 80 
penalty 
IDT-S 78.04 99.83 99.77 99.67 98.72 95.26 96.81 96.71 49.99 1.60 
IDT-M 80.00 99.82 99.72 99.45 97.01 90.60 97.62 97.32 40.49 1.93 
IDT-L 80.29 99.82 99.63 98.89 93.99 85.11 97.55 96.73 37.28 2.28 
Roche-S 80.30 99.88 99.55 98.96 96.71 91.89 96.29 95.61 35.46 1.86 
Roche-M* 66.83 99.85 99.40 98.54 94.63 86.06 96.99 96.01 33.74 1.91 
Roche-L 79.52 99.85 99.49 98.83 95.99 89.65 97.04 96.30 28.82 2.01 
Agilent-S 77.73 99.65 99.15 98.25 94.79 88.17 97.58 96.58 32.79 2.05 
Agilent-M 80.01 99.64 99.30 98.76 96.26 90.63 98.23 97.64 30.29 1.95 
Agilent-L 76.42 99.66 99.27 98.55 94.99 87.51 98.20 97.39 26.82 2.05 
Twist-S 80.00 99.86 99.81 99.65 97.94 94.22 95.52 95.36 45.67 1.58 
Twist-M 79.96 99.84 99.78 99.70 99.08 97.11 96.58 96.51 33.52 1.42 
Twist-L 80.05 99.84 99.78 99.69 98.93 96.66 96.58 96.50 32.17 1.45 
 
Table 4. The 80X mapped dataset.  
For each platform and DNA fragment length combination, the 80 mapped X-fold coverage 
is shown for the target design dataset (mean of the three independent experiments). The 
columns show the mapped coverage on the target, percentage of the target covered by at 
least 1, 5, 10, 20 and 30 reads, percentage of callable bases on the target for standard read 
depth (>3) and read depth >10, fold enrichment and FOLD 80 base penalty. DNA fragment 
lengths: S = short, M = medium, L = long. 
* The sequencing data available for this combination did not reach 80X mapped coverage. 
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The 80X dataset (on RefSeq genes) 
 
The same calculation was performed for the RefSeq genes using the downsampled 
BAM files at 80X mapped coverage on the target designs. This dataset focused only 
on the reads mapping on the genes regions (defined by the RefSeq database), since 
according to the literature the clinical interest is mostly on the protein-coding part 
of the genome. Results of the influence of DNA fragment length on the 
genotypability of each gene showed similar trends to those described above (Table 
5). The higher genotypability was obtained using the medium and the long DNA 
fragments for all platforms. 
 
ID Mapped 
coverage 
(X) 
%1X %5X %10X %20X %30X % PASS % 
PASS 
RD>10 
Fold 
enrichment 
FOLD 80 
penalty 
IDT-S 78.43 99.16 99.02 98.93 98.15 94.96 95.72 95.63 50.41 1.60 
IDT-M 79.36 99.22 99.03 98.73 96.21 89.55 96.59 96.27 40.31 1.95 
IDT-L 79.61 99.26 98.96 98.17 93.07 83.84 96.54 95.68 37.10 2.31 
Roche-S 82.94 99.80 99.48 98.99 97.31 93.82 96.21 95.67 36.62 1.74 
Roche-M* 69.35 99.77 99.36 98.69 95.77 89.05 96.98 96.23 35.01 1.81 
Roche-L 83.25 99.79 99.44 98.93 96.82 91.89 97.03 96.47 30.18 1.92 
Agilent-S 86.86 99.76 99.44 98.91 96.60 91.58 96.28 95.73 36.63 2.01 
Agilent-M 89.27 99.72 99.39 98.97 97.20 93.02 97.03 96.60 33.80 1.94 
Agilent-L 86.23 99.74 99.37 98.79 96.06 90.20 96.99 96.37 30.26 2.08 
Twist-S 79.50 99.81 99.75 99.60 97.90 94.18 96.18 96.04 45.39 1.58 
Twist-M 79.96 99.80 99.73 99.67 99.09 97.19 97.13 97.07 33.51 1.41 
Twist-L 80.08 99.81 99.73 99.65 98.94 96.74 97.14 97.06 32.18 1.44 
 
Table 5. The 80X mapped dataset (RefSeq genes). 
For each platform and DNA fragment length combination, the 80 mapped X-fold coverage 
is shown for the target design dataset (mean of the three independent experiments). The 
columns show the mapped coverage on the target, percentage of the target covered by at 
least 1, 5, 10, 20 and 30 reads, percentage of callable bases on the target for standard read 
depth (>3) and read depth >10, fold enrichment and FOLD 80 base penalty. DNA fragment 
lengths: S = short, M = medium, L = long. 
* The sequencing data available for this combination did not reach 80X mapped coverage. 
 
I then focused the analysis on the number of RefSeq genes which could reach 100% 
genotypability in all the platforms using different DNA fragment lengths (Table 6). 
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In three of the four platforms, the medium length obtained more 100% callable 
genes, as Roche obtained the highest value using the long DNA fragments. The best 
result was obtained by Twist-M (17,709 genes), while the worst value was obtained 
by Agilent-S (16,053 genes), with a difference of 1656 genes. 
 
Enrichment platform 
Average DNA fragment size 
Short (S) Medium (M) Long (L) 
IDT 16,430 16,823 16,144 
Roche 16,091 16,299 16,599 
Agilent 16,053 16,869 16,547 
Twist 16,812 17,709 17,706 
 
Table 6. Number of RefSeq genes reaching 100% genotypability. 
Number of RefSeq genes reaching 100% genotypability at 80X mapped coverage on the 
target design dataset using different platforms and DNA fragment lengths. 
 
Aggregating the results of increased genotypability for each platform, many RefSeq 
genes could reach 100% genotypability from short-to-medium and short-to-long 
fragment extension (840-1330) (Table 7 and Figure 21). Considering the genes 
which showed any increase in genotypability, the number was even higher (1837-
2429). For a minimal number of genes, a decrease in genotypability was observed 
increasing the DNA fragment length. 
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Dataset IDT Roche Agilent Twist 
RefSeq genes – up to 100% 
genotypability 
840 1007 1330 1107 
RefSeq genes – increased 
genotypability 
1837 2247 2429 1993 
OMIM genes – up to 100% 
genotypability 
156 125 270 232 
OMIM genes – increased 
genotypability 
321 288 459 370 
 
Table 7. Number of genes showing increased genotypability. 
Number of RefSeq and OMIM genes showing increased genotypability following the 
extension of the DNA fragment size from short to medium, or short to long, at 80X mapped 
coverage on each target design. 
 
The genes associated with a clinical phenotype (derived from the OMIM database) 
were investigated to analyse the improvement in genotypability through the 
extension of the DNA fragment length. 125-270 OMIM genes could reach 100% 
genotypability from short-to-medium and short-to-long fragment extension, and 
considering the genes which showed any increase in genotypability, the number 
achieved was 288-459. As seen before, for a minimal number of genes there was a 
decrease in genotypability with the increase of the DNA fragment length. 
  
 
 
51 
 
 
 
 
I then ranked by improvement in genotypability the OMIM genes and took the top 
20 considering both the improvements between the short and the medium size and 
between the short and the long size (Table 8). The difference between short and 
longer fragments showed that, at same coverage levels, the genotypability of the 
target region could increase up to 53%.  
Figure 21. RefSeq/OMIM genes reaching 100% genotypability. 
Number of RefSeq (A) and OMIM (B) genes reaching 100% genotypability at 80X mapped 
coverage on each target design using different DNA fragment lengths. 
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Table 8. Top 20 OMIM genes showing the best improvement in genotypability. 
Top 20 OMIM genes showing the best improvement in genotypability following the 
extension of the DNA fragment length from short to medium and short to long (Twist 
enrichment platform). The data represent the maximum difference in genotypability at 80X 
mapped coverage on the Twist design. DNA fragment lengths: S = short, M = medium, L 
= long. 
 
  
OMIM 
% Genotypability 
% Diff. 
%10X Coverage 
S M L S M L 
RPS26 47.13 100 100 52.87 100 100 100 
RPL15 49.98 100 100 50.02 99.90 100 100 
RPL21 60.60 100 100 39.4 100 100 100 
RPSA 63.29 100 100 36.71 100 100 100 
GCSH 64.56 100 97.38 35.44 100 100 100 
HNRNPA1 66.84 100 100 33.16 100 100 100 
CISD2 53.37 85.15 100 31.78 100 100 100 
IFNL3 69.43 100 100 30.57 100 100 100 
LEFTY2 74.00 100 100 26.00 100 100 100 
BMPR1A 74.19 100 100 25.81 100 100 100 
RPS23 75.00 100 100 25.00 100 100 100 
ISCA1 75.13 100 100 24.87 100 100 100 
ALG10 75.15 100 100 24.85 100 100 100 
IFITM3 77.53 100 100 22.47 100 100 100 
PTEN 78.55 100 100 21.45 98.49 100 100 
BANF1 78.64 100 100 21.36 100 100 100 
HLA-A 79.02 100 100 20.98 99.88 100 99.82 
RPS28 80.79 100 100 19.21 100 100 100 
RP9 78.88 97.60 100 18.72 100 100 100 
CYP11B1 81.73 100 100 18.27 100 100 100 
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The multiple-downsampling dataset 
 
Finally, I evaluated the influence at different coverage levels of the DNA fragment 
size and enrichment uniformity on genotypability of the target. Therefore, I 
produced downsampled BAM files (with an average X-fold coverage of 10–80) on 
the corresponding target designs. Since coverage levels are considered fundamental 
in the evaluation of WES performances, I compared: coverage of the target at 
different thresholds (1X, 5X, 10X, 20X, 30X), genotypability (% PASS and % 
PASS RD>10), the fold enrichment and the FOLD 80 values through a variable 
mapped coverage.  
I initially focused on the single effect of enrichment uniformity on genotypability 
at 10-80X mapped coverage. I performed a comparison between the platform with 
the best enrichment uniformity (lower FOLD 80 value), Twist, and the one with the 
highest FOLD 80 value, Agilent, considering a fixed DNA fragment length 
(medium) (Table 9). Twist with its higher uniformity (1.42-1.58) could reach 
saturation of genotypability at 60X mapped coverage (96.57% for % PASS and 
96.40% for % PASS RD>10), while Agilent with higher FOLD 80 values (1.94-
2.39) could not reach the same callability (96.31% and 96.40% for % PASS and % 
PASS RD>10, respectively, at 80X mapped coverage). The percentage of the target 
covered by at least 30 reads (%30X) reflected the higher uniformity of Twist 
already at 60X in respect of Agilent.  
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Mapped 
coverage (X) 
%1X %5X %10X %20X %30X 
% 
PASS 
% PASS 
RD>10 
Fold enrichment 
FOLD 80 
penalty 
Twist-M 
80 99.84 99.78 99.70 99.08 97.11 96.58 96.51 33.52 1.42 
70 99.84 99.77 99.66 98.66 95.67 96.57 96.47 33.51 1.42 
60 99.83 99.76 99.58 97.87 93.03 96.57 96.40 33.52 1.42 
50 99.83 99.73 99.40 96.32 87.50 96.55 96.21 33.51 1.44 
40 99.82 99.68 98.94 92.62 74.75 96.53 95.77 33.51 1.46 
30 99.81 99.49 97.55 81.67 47.28 96.45 94.39 33.51 1.50 
20 99.79 98.64 91.45 47.98 11.39 96.02 88.26 33.51 1.58 
10 99.54 89.28 49.25 3.28 0.38 90.86 46.27 33.51 1.58 
Agilent-M 
80 99.78 99.45 98.86 96.41 90.93 96.31 95.72 30.41 1.94 
70 99.76 99.37 98.62 95.16 87.38 96.27 95.50 30.41 1.95 
60 99.75 99.27 98.24 93.00 81.79 96.21 95.16 30.41 1.96 
50 99.73 99.09 97.54 89.08 73.10 96.12 94.51 30.41 1.97 
40 99.69 98.78 96.10 81.57 59.87 95.96 93.13 30.41 1.98 
30 99.63 98.05 92.40 67.22 40.83 95.56 89.53 30.41 2.00 
20 99.47 95.47 80.96 41.50 17.69 94.11 78.27 30.42 2.13 
10 98.63 80.04 43.34 8.65 1.84 84.16 41.31 30.41 2.39 
 
Table 9. Downsampled mapped coverage. 
Parameters were calculated on 10–80X downsampled sets, including mapped coverage on 
the target, percentage of the target covered by at least 1, 5, 10, 20 and 30 reads, percentage 
of callable bases on the target for standard read depth (>3) and read depth >10, fold 
enrichment and FOLD 80 base penalty. 
 
Then I focused on the single effect of the DNA fragment size on genotypability at 
10-80X mapped coverage. I performed a comparison between two different DNA 
fragment lengths (short and long) on the same platform (IDT), which showed a very 
high variability in enrichment uniformity using different fragment lengths (1.60-
1.86 for S and 2.26-2.35 for L) (Table 10). Again, the %30X reflected the FOLD 
80 values based on the use of the short and the long lengths. In particular, the long 
fragments produced a higher number of over-represented regions at 10-20X 
mapped coverage in respect of the short fragments. On the contrary, at higher 
mapped coverage levels (40-80X) the %10X was lower for the long fragments, 
suggesting an uneven distribution of longer reads. With regard to genotypability, 
longer fragments achieved higher values already at 40X, but the % PASS RD>10 
did not performed as well (91.32% for IDT-L against 95.61% for IDT-S at 40X 
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mapped coverage). In this case, the lower enrichment uniformity of IDT-L 
negatively effected the genotypability of longer DNA fragments. 
 
Mapped 
coverage (X) 
%1X %5X %10X %20X %30X 
% 
PASS 
% PASS 
RD>10 
Fold 
enrichment 
FOLD 80 
penalty 
IDT-S 
80 99.88 99.84 99.73 98.77 95.48 96.84 96.72 50.05 1.60 
70 99.83 99.77 99.62 98.18 93.15 96.81 96.66 49.98 1.60 
60 99.82 99.75 99.51 96.94 88.62 96.80 96.54 49.99 1.61 
50 99.82 99.72 99.25 94.25 80.45 96.79 96.29 49.99 1.60 
40 99.81 99.64 98.57 88.18 65.63 96.74 95.61 49.99 1.62 
30 99.80 99.38 96.34 73.74 40.61 96.62 93.38 49.98 1.64 
20 99.77 98.04 86.96 41.40 11.46 95.95 84.03 49.99 1.69 
10 99.42 85.07 43.50 4.75 1.72 88.31 40.93 49.99 1.86 
IDT-L 
80 99.82 99.63 98.89 93.98 85.10 97.56 96.73 37.28 2.28 
70 99.81 99.56 98.44 91.65 80.56 97.51 96.27 37.28 2.26 
60 99.80 99.44 97.67 88.17 74.47 97.45 95.50 37.28 2.28 
50 99.79 99.20 96.28 82.84 66.15 97.31 94.08 37.28 2.34 
40 99.77 98.65 93.54 74.46 54.62 96.99 91.32 37.29 2.34 
30 99.72 97.23 87.75 60.97 38.36 96.14 85.47 37.28 2.34 
20 99.54 92.90 74.56 38.95 17.37 93.33 72.26 37.28 2.35 
10 98.21 74.64 40.47 8.48 2.36 79.91 38.37 37.29 2.35 
 
Table 10. Downsampled mapped coverage. 
Parameters were calculated on 10–80X downsampled sets, including mapped coverage on 
the target, percentage of the target covered by at least 1, 5, 10, 20 and 30 reads, percentage 
of callable bases on the target for standard read depth (>3) and read depth >10, fold 
enrichment and FOLD 80 base penalty. 
 
Finally, I evaluated the combined effect of DNA fragment extension with 
enrichment uniformity on genotypability at 10-80X mapped coverage. I compared 
different DNA fragment lengths (short and medium) on the platform which showed 
the best enrichment uniformity (1.42-1.58) with longer fragments (Twist) (Table 
11). Results showed that both the DNA fragments could reach saturation of 
genotypability already at 60X mapped coverage, but with a substantial difference 
of 1% more for the medium fragments for % PASS (96.57% for Twist-M against 
95.50% for Twist-S) and % PASS RD>10 (96.40% for Twist-M against 95.01% for 
Twist-S). Therefore, the combined effect of higher enrichment uniformity and 
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extension of DNA fragment length led to better genotypability, especially for 
clinically-relevant thresholds. 
 
Mapped 
coverage (X) 
%1X %5X %10X %20X %30X 
% 
PASS 
% PASS 
RD>10 
Fold enrichment 
FOLD 80 
penalty 
Twist-S 
80 99.86 99.81 99.65 97.94 94.22 95.52 95.36 45.67 1.58 
70 99.86 99.79 99.52 97.02 92.09 95.51 95.25 45.68 1.58 
60 99.86 99.77 99.28 95.56 88.66 95.50 95.01 45.67 1.60 
50 99.85 99.71 98.80 93.13 82.65 95.48 94.53 45.67 1.60 
40 99.84 99.56 97.74 88.39 70.86 95.41 93.50 45.67 1.62 
30 99.83 99.09 95.29 77.32 47.59 95.18 91.09 45.67 1.66 
20 99.78 97.36 87.52 47.91 13.60 94.22 83.48 45.67 1.71 
10 99.30 86.10 48.97 4.46 0.59 87.35 45.76 45.67 1.88 
Twist-M 
80 99.84 99.78 99.70 99.08 97.11 96.58 96.51 33.52 1.42 
70 99.84 99.77 99.66 98.66 95.67 96.57 96.47 33.51 1.42 
60 99.83 99.76 99.58 97.87 93.03 96.57 96.40 33.52 1.42 
50 99.83 99.73 99.40 96.32 87.50 96.55 96.21 33.51 1.44 
40 99.82 99.68 98.94 92.62 74.75 96.53 95.77 33.51 1.46 
30 99.81 99.49 97.55 81.67 47.28 96.45 94.39 33.51 1.50 
20 99.79 98.64 91.45 47.98 11.39 96.02 88.26 33.51 1.58 
10 99.54 89.28 49.25 3.28 0.38 90.86 46.27 33.51 1.58 
 
Table 11. Downsampled mapped coverage. 
Parameters were calculated on 10–80X downsampled sets, including mapped coverage on 
the target, percentage of the target covered by at least 1, 5, 10, 20 and 30 reads, percentage 
of callable bases on the target for standard read depth (>3) and read depth >10, fold 
enrichment and FOLD 80 base penalty. 
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Variant calling results 
 
To assess the effects of the improvement in genotypability through the combination 
of the DNA fragment extension and a high enrichment uniformity, the variant 
calling was performed on each of the three individuals. The variant calling could 
evaluate the difference in the number of variants identified using short and longer 
DNA fragments due to the higher number of callable bases achieved in all 
platforms.  
For each sample, I used the HaplotypeCaller software (v4.1.2.0) to identify the 
genetic variants in respect of the human genome reference sequence. Variants were 
filtered using the target design regions of Twist, which showed the best results in 
terms of genotypability of the target after the extension of the DNA fragments, and 
results were aggregated by the mean values obtained from the individuals (Table 
12). Results showed an increase of >1% in both the short-to-medium and short-to-
long fragment extensions. The same >1% increase with longer DNA fragments was 
observed for the number of variants identified in the RefSeq and OMIM genes 
included in the target design. These results reflected the same trend seen for the 
genotypability (1% increase) in genotypability achieved by increasing the length of 
the DNA fragments. 
 
DNA fragment size #variants in 
design 
#variants in RefSeq 
genes 
#variants in OMIM 
Genes 
S 23,140 20,279 5,008 
M 23,461 20,509 5,057 
L 23,521 20,576 5,074 
 
Table 12. Variants in the Twist target design (HaplotypeCaller). 
Total number of variants identified in the Twist target design, and in the corresponding 
RefSeq and OMIM genes, for each DNA fragment size (S = short, M = medium, L = long). 
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WES performances on 9 different DNA fragment lengths 
 
The evaluation of the WES performance for 3 different DNA fragment lengths 
(∼200, ∼350 and ∼500 bp) showed relevant differences in terms of genotypability 
of the ROI. The highest change in genotypability was identified between the short 
and the medium fragments, whose difference in terms of length was not trivial (150 
bp). To identify the presence of a threshold above which the genotypability of the 
ROI could significantly improve, I isolated 27 individuals from almost 1,000 
exomes processed with the Twist platform in over a year. These samples could 
represent nine different DNA fragment lengths (200, 230, 260, 270, 280, 290, 340, 
360 and 400 bp) in replicates of three. The developed bioinformatics pipeline was 
then used to analyse this new set of samples. 
For the initial dataset of 27 samples, statistics were calculated considering: the total 
number of sequenced fragments, the GC percentage, the theoretical coverage, the 
mapped deduplicated reads, the average insert size, the percentage of duplicates and 
the mapped coverage (Table 13).  
The dataset showed many differences at the level of fragments produced and in the 
number of mapped deduplicated reads, as previously seen. Theoretical coverage 
varied from 198X to 464X, whereas the mapped coverage varied from 80 to 136X 
(Figure 22). The percentage of duplicates was also very variable (7-20%) (Figure 
23). To compute an unbiased comparison of WES performances, the dataset was 
aggregated by the mean values obtained for each group of individuals, and then 
subdivided in normalized datasets using the theoretical coverage (200X) and the 
mapped coverage (80X) on the target design, as performed previously.  
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ID Sequenced 
fragments 
GC% Design length Theoretical 
coverage (X) 
Mapped 
deduplicated 
fragments 
Average 
insert size 
% 
Duplicates 
Mapped 
coverage 
(X) 
VR00_200 58,092,508 52 36,715,240 237.34 51,158,376 209.79 8.01 101.11 
NA12891_200 62,145,209 52 36,715,240 253.89 53,990,842 211.43 9.24 106.91 
NA12892_200 58,556,655 52 36,715,240 239.23 51,774,402 207.55 7.76 102.74 
VR00_230 48,873,712 51 36,715,240 199.67 42,612,354 222.17 9.03 82.13 
NA12891_230 48,612,772 52 36,715,240 198.61 41,948,721 236.17 9.57 80.02 
NA12892_230 53,294,072 52 36,715,240 217.73 45,120,197 244.94 11.22 85.21 
3234V_260 38,894,499 49 36,715,240 317.81 35,348,300 261.83 8.42 93.92 
2852T_260 35,460,051 49 36,715,240 289.74 32,054,884 261.88 8.91 85.38 
3258V_260 55,593,344 49 36,715,240 454.25 50,254,880 263.55 8.98 132.45 
376V_270 51,391,218 49 36,715,240 419.92 46,352,045 269.72 9.09 122.61 
3260V_270 38,768,558 49 36,715,240 316.78 35,472,484 270.95 7.72 95.64 
3233V_270 37,135,966 49 36,715,240 303.44 33,726,602 272.39 8.38 90.85 
603V_280 39,062,497 49 36,715,240 319.18 35,586,582 282.06 8.08 94.62 
19N0175_280 44,493,206 48 36,715,240 363.55 40,179,822 282.23 8.91 107.87 
3269V_280 42,372,135 48 36,715,240 346.22 38,497,147 281.65 8.39 103.36 
377V_290 45,368,031 48 36,715,240 370.70 41,185,643 288.65 8.49 110.41 
19N0104_290 37,116,772 49 36,715,240 303.28 33,657,874 291.56 8.39 89.46 
3778V_290 35,789,884 48 36,715,240 292.44 32,646,350 292.83 7.86 86.80 
VR00_340 52,398,002 48 36,715,240 428.14 41,262,820 323.46 20.01 108.73 
NA12891_340 48,348,995 48 36,715,240 395.06 38,860,722 338.35 18.23 102.00 
NA12892_340 51,378,070 48 36,715,240 419.81 41,175,544 339.21 18.42 107.62 
VR00_360 49,286,947 49 36,715,240 402.72 42,067,556 360.41 12.36 121.92 
NA12891_360 45,101,242 49 36,715,240 368.52 37,418,907 390.49 14.57 106.47 
NA12892_360 53,142,446 49 36,715,240 434.23 44,835,844 360.36 13.57 131.09 
VR00_400 53,025,771 48 36,715,240 433.27 46,216,132 400.91 9.92 128.25 
NA12891_400 56,814,853 49 36,715,240 464.23 48,349,215 389.09 12.24 136.39 
NA12892_400 53,633,893 49 36,715,240 438.24 46,784,910 411.80 9.39 130.16 
 
 
Table 13. WES initial dataset. 
For each replicate and DNA fragment length combination, the number of sequenced 
fragments, percentage GC content, theoretical coverage, number of mapped fragments 
without duplicates, average insert size, percentage of reads marked as duplicates and 
mapped coverage on the target are shown.  
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Figure 22. Theoretical and mapped coverage. 
For each replicate and DNA fragment length, theoretical coverage and mapped coverage on the 
target are plotted. 
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Figure 23. Duplicates rate. 
For each replicate and DNA fragment length, the duplicates rate is plotted. 
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The 200X dataset 
 
From the initial dataset of sequenced reads representing each sample, I produced 
downsampled BAM files with a 200 theoretical X-fold coverage (the maximum 
mapped coverage value obtained by all the samples) on the target design (Table 14). 
As parameters for comparison I considered: the on/near/off target rate, the fold 
enrichment, the FOLD 80 values and the percentage of duplicates.  
 
 
Table 14. The 200X dataset.  
For each DNA fragment length, the 200 theoretical X-fold coverage is shown for the target 
design dataset (mean of the three independent experiments). The columns show the average 
insert size, mapped coverage on the target, percentage of the target covered by at least 1, 
5, 10, 20 and 30 reads, percentage of callable bases on the target for standard read depth 
(>3) and read depth >10, percentage of bases on/near/off target, fold enrichment and 
FOLD 80 base penalty. 
 
I evaluated the number of sequenced bases near and off the target and the frequency 
of duplicates obtained. The extension of the DNA fragment length from 200 to 400 
bp generally decreased the on-target rate, except for the 360 and the 400 bp length. 
As expected, the near-target increased from the short to longer libraries, while the 
off-target rate showed lower values only for very short (200-230 bp) or longer 
fragments (360-400 bp), reflecting a higher cross-hybridization to regions outside 
of the target for fragments between 260 and 340 bp. The highest frequency of 
duplicates was generated by the 230 and 340 bp length (9–10%), followed by 200 
and 360 bp (6-7%). On the contrary, fragment lengths between 260 and 290 bp, 
DNA 
fragment 
length 
Average 
insert size 
% 
Duplicates 
Mapped 
coverage 
(X) 
%1X %5X %10X %20X %30X % 
PASS 
% PASS 
RD>10 
% ON 
TARGET 
% NEAR 
TARGET 
% OFF 
TARGET 
Fold 
enrichment 
FOLD 80 
penalty 
200 206.28 6.29 87.30 99.86 99.82 99.70 98.36 95.22 95.50 95.39 52.36 32.96 14.68 45.89 1.58 
230 231.64 9.24 80.90 99.86 99.82 99.71 98.40 95.17 95.53 95.43 49.78 35.58 14.63 43.63 1.53 
260 262.34 5.31 61.15 99.80 99.72 99.64 99.32 97.15 96.38 96.33 40.20 36.52 23.28 35.23 1.36 
270 270.91 5.08 61.86 99.78 99.71 99.64 99.34 97.33 96.41 96.36 39.73 37.21 23.06 34.82 1.36 
280 281.83 5.11 61.81 99.78 99.69 99.61 99.25 97.03 96.42 96.35 38.70 37.43 23.87 33.92 1.38 
290 290.87 5.32 61.37 99.79 99.69 99.61 99.24 96.87 96.43 96.35 37.89 38.05 24.06 33.21 1.38 
340 334.18 10.16 57.26 99.83 99.74 99.63 98.96 94.90 96.54 96.44 36.35 40.44 23.20 31.86 1.38 
360 366.62 7.18 64.74 99.83 99.76 99.60 98.16 94.11 96.58 96.43 38.80 45.65 15.56 34.00 1.44 
400 396.33 4.94 63.50 99.83 99.75 99.56 97.78 93.14 96.59 96.39 37.16 47.03 15.81 32.57 1.48 
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followed by the longest fragment size (400 bp) seemed to optimize the frequency 
of duplicates for this platform. As previously observed, the differences in off-target 
and duplicates rates resulted in a variability in the mapped coverage values. 
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The 80X dataset (on design and RefSeq genes) 
 
The same calculation was performed for the design target regions and the RefSeq 
genes, using the downsampled BAM files at 80X mapped coverage on the target 
designs (Table 15 and 16). As parameters for comparison I considered: coverage at 
different thresholds (1X, 5X, 10X, 20X, 30X), genotypability (% PASS and % 
PASS RD>10), the fold enrichment and the FOLD 80 values. Results confirmed 
the trend previously seen. Genotypability increased when optimizing uniformity of 
enrichment and increasing DNA fragment length, especially between the 260 and 
the 340 bp DNA fragment length. For the design target region, % PASS jumped 
from 95.52% to 96.38% using the 230 bp and 260 bp lengths, respectively. FOLD 
80 decreased from 1.58 to 1.34, concomitantly. Enrichment uniformity started to 
decrease from the 360 bp length (1.42-1.45), which already obtained saturation in 
terms of genotypability. 
 
 
DNA fragment 
length 
Mapped 
coverage (X) 
%1X %5X %10X %20X %30X % PASS % PASS 
RD>10 
Fold 
enrichment 
FOLD 80 
penalty 
200 80.72 99.86 99.82 99.71 98.42 95.21 95.55 95.45 43.50 1.53 
230 80.00 99.86 99.81 99.65 97.94 94.22 95.52 95.36 45.67 1.58 
260 79.99 99.81 99.73 99.68 99.54 99.13 96.38 96.34 35.13 1.34 
270 79.97 99.79 99.72 99.67 99.54 99.13 96.40 96.37 34.72 1.34 
280 80.00 99.79 99.71 99.65 99.48 99.01 96.43 96.38 33.79 1.36 
290 80.02 99.80 99.71 99.65 99.49 99.01 96.43 96.38 33.10 1.36 
340 79.99 99.84 99.78 99.71 99.50 98.88 96.53 96.47 31.59 1.37 
360 79.96 99.84 99.78 99.70 99.08 97.11 96.58 96.51 33.52 1.42 
400 80.05 99.84 99.78 99.69 98.93 96.66 96.58 96.50 32.17 1.45 
 
 
Table 15. The 80X mapped dataset.  
For each DNA fragment length, the 80 mapped X-fold coverage is shown for the target 
design dataset (mean of the three independent experiments). The columns show the mapped 
coverage on the target, percentage of the target covered by at least 1, 5, 10, 20 and 30 
reads, percentage of callable bases on the target for standard read depth (>3) and read 
depth >10, fold enrichment and FOLD 80 base penalty.  
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Similar results were obtained for the RefSeq genes. Genotypability increased at 
lower FOLD 80 values, with a leap between the 230 bp and the 260 bp length (% 
PASS jumped from 95.81% to 96.58%, respectively). Above the 230 bp length, the 
FOLD 80 decreased (1.58-1.34), together with an increase of the genotypability. 
Enrichment uniformity started to decrease from the 360 bp length (1.42-1.44), 
which again obtained saturation in terms of genotypability. 
 
 
DNA fragment 
length 
Mapped 
coverage (X) 
%1X %5X %10X %20X %30X % PASS % PASS 
RD>10 
Fold 
enrichment 
FOLD 80 
penalty 
200 80.18 99.71 99.63 99.53 98.23 95.02 95.84 95.74 43.21 1.52 
230 79.45 99.71 99.62 99.46 97.74 94.00 95.81 95.65 45.36 1.58 
260 79.59 99.69 99.54 99.49 99.37 98.99 96.58 96.54 34.95 1.34 
270 79.55 99.68 99.54 99.49 99.37 98.99 96.60 96.56 34.54 1.34 
280 79.99 99.69 99.53 99.47 99.32 98.92 96.63 96.57 33.78 1.35 
290 79.84 99.70 99.54 99.47 99.33 98.89 96.64 96.58 33.02 1.37 
340 79.71 99.75 99.60 99.54 99.36 98.79 96.75 96.68 31.48 1.37 
360 79.83 99.72 99.61 99.53 98.94 97.02 96.81 96.73 33.46 1.42 
400 79.94 99.73 99.61 99.52 98.79 96.56 96.82 96.72 32.13 1.44 
 
 
Table 16. The 80X mapped dataset.  
For each DNA fragment length, the 80 mapped X-fold coverage is shown for the RefSeq 
genes dataset (mean of the three independent experiments). The columns show the mapped 
coverage on the target, percentage of the target covered by at least 1, 5, 10, 20 and 30 
reads, percentage of callable bases on the target for standard read depth (>3) and read 
depth >10, fold enrichment and FOLD 80 base penalty.  
 
The trend obtained for the FOLD 80 and the genotypability values (% PASS and % 
PASS RD>10) was plotted against the respective DNA fragment lengths (Figure 
20). The enrichment uniformity showed a decrease (increase in the curve) above 
the 260 bp length, indicating that longer DNA fragments did not optimize the 
coverage uniformity, for both the design and RefSeq genes regions (Figure 24 A-
B). However, longer DNA fragments increased the genotypability for both % PASS 
and % PASS RD>10 values, as uniformity of coverage was sufficient to allow good 
performances in base calling (Figure 24 C-D). In particular, a remarkable leap 
(more than 1%) of genotypability was evident between the 230 bp and the 260 bp 
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DNA fragment length. From the 260 bp length, results showed a less evident 
increase in genotypability, indicating that satisfactory base calling could be 
obtained already at this threshold. The decrease in enrichment uniformity 
observable from the 360 bp length (which was related to an increase in the 
genotypability of a few percentage points), pointed out that base calling was not 
strictly influenced by the FOLD 80 value, but more by the DNA fragment length. 
 
 
 
 
 
Figure 24. Tendency of FOLD 80 penalty and genotypability at different insert sizes.  
The figure shows the FOLD 80 base penalty and genotypability values at different insert 
sizes considering the target design (A-C) and the RefSeq genes (B-D) regions. 
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DISCUSSION 
 
The current challenges for the bioinformatics data analysis of NGS data are several, 
from the correct alignment of the sequenced reads on the reference genome to the 
accurate variant calling. Software benchmarking could help in the decision of 
finding the most accurate pipeline to use [28][29][30], but some limitations are still 
present. Alignment of reads in repetitious regions of the genome yet leads to 
segments of the genome not investigable [8] and variant calling provides an 
incomplete genetic information (VCF files), as invariant sites cannot be further 
analysed. Moreover, data derived from samples processed using different 
enrichment technologies are analysed considering only the depth and uniformity of 
coverage [16], whereas regions highly-covered cannot always ensure a high 
confidence of the alignment. This work aimed to improve the bioinformatics 
analysis of targeted resequencing and subsequently ameliorate the current 
limitations of the analysis. 
Considering that the solely depth of coverage could be misleading for the data 
analysis, a new metric was included, namely the genotypability. This value, which 
reflects both the depth of coverage and the quality of the alignment at a specific 
genomic site, was calculated integrating the CallableLoci tool in the The Genome 
Analysis Toolkit Best Practices Workflow. In this way, callable regions of any ROI 
(i.e. the design or the coding regions of the genome) could be provided, so that the 
consequent variant calling could produce adequate files for a potential clinical 
setting (gVCF files). Several standard parameters generally used for the assessment 
of WES performance were also integrated within the pipeline, however 
genotypability could show a substantial difference from other metrics, especially 
from the depth of coverage. From a single initial experiment sequenced at very high 
coverage levels (200X), results showed that whereas optimal coverage levels on the 
entire target could be obtained only a high mapped coverage, genotypability 
increased to reach saturation at coverage levels usually considered low for WES 
[31]. For this reason, contrary to what is expected, deeper sequencing would be 
useless as the callability would not improve at higher coverage levels. 
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While the lack of sequencing in some regions could be ameliorated increasing the 
depth of coverage, the genotypability clearly showed a different trend. For this 
reason, there was a need to improve the alignment of reads at low quality, as the 
base calling is directly influenced by that. The approach was then to extend the 
DNA fragment length so that one of the read pairs could align outside of the exonic 
regions to reach the introns, known to be under greater evolutionary constraints 
[32]. Therefore, the bioinformatics pipeline developed was applied on three 
biological replicates sequenced using different enrichment technologies (as they 
provide a variability with regards to the target region) and extending the DNA 
fragment to a medium (∼350 bp) and a long (∼500 bp) size.  
Overall, independently from the ROI (enrichment platform), the extension of the 
DNA fragment size could always provide a better genotypability of the target. Thus, 
an improvement of the read alignment could effectively be obtained. Indeed, many 
genes derived from the RefSeq gene dataset at 80X mapped coverage improved 
their mappability, including genes of known clinical interests. This result was 
relevant in light of the challenges posed by the American College of Medical 
Genetics and Genomics (ACMG), that already stressed the importance of detecting 
disease-causing variants in repetitious regions of the genome [2]. Among the genes 
that improved their genotypability, RPS26 and RPL15 (associated with the bone 
marrow disorder Diamond-Blackfan anemia according to the OMIM database) 
obtained 100% base calling extending the DNA fragment from short to medium 
(starting from a callability of 47.13% for RPS26 and 49.98% for RPL15). RPSA, 
which is associated with the immunodeficiency disease isolated congenital 
asplenia, also reached 100% from 63.29% extending the DNA fragments, and 
similarly the tumor suppressor gene PTEN could also obtain 100% (starting from 
78.55% using short fragments). This means that these genes of medical relevance 
contained regions of low mapping quality that could potentially harbour pathogenic 
variants otherwise neglected.  
This result was confirmed with the variant calling performed on the replicates, 
which on average provided an increase in the number of variants of ∼1%, the same 
increase showed for the genotypability metric. This proved again an effective 
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improvement of the read alignment in regions previously considered uncallable, but 
also the presence of a consistent number of variants present in repetitious genomic 
regions.  
With regards to uniformity of coverage, the extension of the DNA fragments could 
not clearly determine an improvement, as previously stated [6]. Indeed, for some 
enrichment platforms, longer fragments could improve the coverage uniformity, 
while for others there was no improvement. More generally, with a low uniformity 
of coverage, genotypability was more dependent on the mapped coverage (higher 
coverage = higher genotypability), but with higher uniformity values, the 
genotypability reached saturation at lower coverage levels (60X). This result 
confirmed once more that with a more uniform coverage of the target, deep 
sequencing is not necessary, as genotypability could not further improve. The fold 
enrichment value, which provides the “efficiency of enrichment” through the 
evaluation of the on-target in respect of the near and off-target rates, did not strongly 
correlate with the genotypability of the target as well. Indeed, low fold enrichment 
values did not correspond to a reduction of callability.  
The number of duplicates obtained for each enrichment platform and DNA 
fragment size combination confirmed as well the importance of the extension of the 
DNA fragment length for the reduction of the sequencing depth, related to the 
reduction of the number of fragments that need to be produced. Indeed, as the use 
of 2 x 75 bp reads requires double the amount of sequencing of the 2 x 150 bp reads, 
the problem of duplicates could be greatly reduced.  
Overall, the most relevant change in genotypability was observed between the short 
(∼200) and the medium (∼350) fragments. This indicated that short fragments 
could successfully improve the read alignment when extended, but the minimum 
extension required to generally overcome repetitious regions was still not known. 
For this reason, nine more different DNA fragment lengths were investigated 
between the short and the medium one. The increase in genotypability between the 
different lengths was continuous, but an evident leap was present between the 230 
and the 260 bp length. The same leap was evident in the uniformity of coverage 
(from 1.58 to 1.34), showing once again that higher enrichment uniformity lead to 
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better genotypability. However, while uniformity slightly started to decrease using 
DNA fragments above 260 bp, the genotypability could still improve. This 
indicated that uniformity of coverage had an influence on genotypability of the 
region, but the major influencing factor was the extension of the DNA fragment 
length. The 1% increase in genotypability was obtained immediately above the 230 
bp, pointing out that this threshold should be used as a minimum requirement for 
the library preparation of samples analysed with the specified enrichment platform. 
Genotypability could still slightly improve, leaving to the single laboratory the 
choice of the more appropriate DNA length to use. Interestingly, the number of 
bases sequenced on-target decreased when increasing the fragment size between 
260 to 340 bp, but genotypability was not affected by that. This proved that fold 
enrichment and uniformity of coverage are still incomplete metrics for the 
evaluation of WES performances. 
Exome sequencing costs could also be reduced through the extension of the DNA 
fragment length. While short DNA fragments generally allows to limit the costs of 
the analysis, longer fragments could improve the quality of the read alignment, 
producing a higher uniformity of coverage and hence reducing the amount of 
sequencing needed to sufficiently cover the entire target region. In this way, the 
overall costs could be reduced and DNA fragment extension revealed to be less 
costly than the increase of the sequencing depth. 
In this thesis work, the performance of WES was evaluated through a metric that 
considered not only the depth and uniformity of coverage of the region 
investigated, but also the quality of the read alignment. Genotypability confirmed 
to be a more informative parameter in the evaluation of WES, and this could be 
improved extending the DNA fragment length. Although the combination of DNA 
fragment size and enrichment platform showed an influence on the base calling, 
this one improved in all cases, even despite slightly worsening of performance of 
the uniformity of coverage. The use of this approach in a clinical setting could 
provide to clinicians the best options from the sample processing to the variant 
calling, even for repetitious genomic regions. The identification of more variants 
in regions difficult to align could provide new insights into human diseases and 
their associations to variants with a biological consequence. 
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